MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Autors de IIS La Fe
Grups d'Investigació
Abstract
Neuroblastoma is an embryonal tumor of neuroectodermal cells. Patients with metastatic neuroblastoma have a poor survival rate, which has led to numerous efforts to develop prognostic markers. Cancer/testis-specific antigens MAGE-A1 and MAGE-A3 genes were proposed as minimal residual disease (MRD) markers in neuroblastoma, but its usefulness for this purpose is rather limited.
Dades de la publicació
- ISSN/ISSNe:
- 0171-5216, 1432-1335
- Tipus:
- Article
- Pàgines:
- 523-531
- PubMed:
- 18820946
- Factor d'Impacte:
- 1,044 SCImago ℠
- Quartil:
- Q1 SCImago ℠
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY SPRINGER
Cites Rebudes en Web of Science: 16
Documents
- No hi ha documents
Filiacions
Projectes associats
ESTUDIO DE FASE I/II DE CP-751,871 EN PACIENTES CON TUMORES DE LA FAMILIA DE SARCOMAS DE EWING RECURRENTES Y/O REFRACTARIOS.
Investigador Principal: VICTORIA CASTEL SÁNCHEZ
A4021020 . 2008